Zinger Key Points
- Icahn Enterprises posted a Q1 loss of $0.79 per share and missed revenue estimates, with EBITDA negative at $(287) million.
- Net asset value dropped $336M, mainly due to $224M in healthcare losses; petroleum segment hit by refinery downtime.
- Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street veteran who consistently finds profits in volatile markets. Claim your 7-day free trial now.
Icahn Enterprises L.P. IEP shares were trading lower in the premarket session on Wednesday after reporting its first-quarter results.
The company reported earnings per share of 79 cents, a loss that missed the street view of 19 cents. Quarterly sales of $2.002 billion also missed the analyst consensus estimate of $2.628 billion.
Adjusted EBITDA loss was $(287) million for the three months ended March 31, compared to an Adjusted EBITDA of $134 million.
As of March 31, net asset value fell by $336 million from December 31, mainly due to $224 million in healthcare investment losses.
Also Read: Carl Icahn Loads Up CVR Energy Stock, Drops $27 Million On Bullish April Binge
On May 5, the board of directors of Icahn Enterprises’ general partner declared a quarterly distribution of $0.50 per depositary unit, which will be paid on or about June 25.
The company exited the quarter with cash and equivalents worth $2.183 billion and inventories worth one billion dollars.
Icahn Enterprises reported a net loss from investment activities worth $(394) million, compared with $(96) million in the year-ago period.
Petroleum’s first-quarter results were hurt by downtime from the Coffeyville refinery turnaround, which was completed in April 2025. During the quarter, the company processed about 120,000 barrels per day.
Price Action: IEP shares were trading lower by 1.89% to $8.560 at last check on Wednesday.
Read Next:
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.